Filter posts

Strong Public Policy is the Bedrock of Biotech Economic Growth

As noted in the recently-released 2017 BIO publication Bioscience Innovation in the States: Job Creation …

California Senate Passed Drug Price Reporting & Transparency Bill

This week the California Senate passed a tremendously flawed bill that would hamper the ability …

BIO Fall IPCC Meeting: Special Offer for First Time In-House Attendees!

Are you a patent practitioner at a biotech company? Is your in-house IP group small, …

Registration for BIO's Fall IP Counsels Committee Conference is NOW OPEN!

Ah, Autumn. A time for pumpkin spice lattes, cozy sweaters, soup, and updates in the …

Group of Inventors Burn Their Patents in Protest

As reported last week by IP Watchdog, the United States Patent and Trademark Office (PTO) …

Weak Patent Law Endangers Healthcare Innovation

Last week The Wall Street Journal published a fascinating expose that pulled back the curtain …

Licensing of Academic Patents Has Contributed Up to $1.3 Trillion to US Economy

The licensing of university research has made a significant contribution to US gross domestic product …

State Leaders Discuss Bioscience Economic Development

This week BIO released Bioscience Innovation in the States: Legislation and Job Creation through Public-Private …

New BIO White Paper Outlines Policies to Better Combat Antimicrobial Resistance

In recent years, the global community has directed a high level of political attention to …

Commonsense Solutions to Lower Drug Costs

With a national debate underway over drug prices, people are looking for ways to help …